Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells.

Biomaterials - 1 May 2013

Montanucci Pia, Pennoni Ilaria, Pescara Teresa, Basta Giuseppe, Calafiore Riccardo

Abstract excerpt

Transplantation of whole human pancreases or isolated islets into patients with type 1 diabetes mellitus has been severely hampered by the scarcity of cadaveric human donor organs, which mandates search for insulin producing cells/tissue source alternatives. Recent progress in stem cell biology h...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipogenesis
Share to Cell Aggregation
Share to Diabetes Mellitus, Experimental

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Insulin Secretion

Share to Multipotent Stem Cells

Share to Neurogenesis

Share to Osteogenesis

Share to Stem Cell Factor

Source

Identifiers

PMID: 23453199
DOI: 10.1016/j.biomaterials.2013.02.026

Genes

PDX1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23453199-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells.PMID 23453199Read ↗

The functional performance of microencapsulated human pancreatic islet-derived precursor cells.Semantic proximity Read ↗

Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype.Semantic proximity Read ↗

A perfect islet: reviewing recent protocol developments and proposing strategies for stem cell derived functional pancreatic isletsSemantic proximity Read ↗

In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cellsSemantic proximity Read ↗

Recent Advances in the Development of Bioartificial Pancreas Using 3D Bioprinting for the Treatment of Type 1 Diabetes: A ReviewSemantic proximity Read ↗

Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In VivoSemantic proximity Read ↗

Stem Cells to Pancreatic β-Cells: New Sources for Diabetes Cell TherapySemantic proximity Read ↗

Manufacturing clinical‐grade human induced pluripotent stem cell‐derived beta cells for diabetes treatmentSemantic proximity Read ↗

Converting human pluripotent stem cells into β-cells: recent advances and future challengesSemantic proximity Read ↗

Forward programming of hiPSCs towards beta-like cells using Ngn3, Pdx1, and MafASemantic proximity Read ↗

Bioprinting of Human Primary and iPSC-derived Islets with Retained and Comparable FunctionalitySemantic proximity Read ↗

Stem Cell Therapy for Diabetes: Beta Cells versus Pancreatic ProgenitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.